Rapid and Simultaneous Quantification of Six Aristolochic Acids and Two Lignans in Asari Radix et Rhizoma Using Ultra-Performance Liquid Chromatography-Triple Quadrupole Tandem Mass Spectrometry

• Published in: Journal of analytical methods in chemistry Vol. 2022; pp. 1 - 9
• Main Authors: Liu, Hanze, Cheng, Xuemei, Guan, Huida, Wang, Changhong
• Format: Journal Article
• Language: English
• Published: New York Hindawi 10-09-2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Acids; Analysis; Analytical chemistry; Biotechnology; Chinese medicine; Chromatography; Control methods; Herbal medicine; High performance liquid chromatography; Ingredients; Instrument industry; Lignans; Markers; Mass spectrometry; Methods; Pharmacology; Provenance; Quadrupoles; Quality control; Quality standards; Scientific imaging; Spectroscopy; Toxicity; United States; Massachusetts; China; United States > US
• ISSN: 2090-8865; 2090-8873
• DOI: 10.1155/2022/5269545

Asari Radix et Rhizoma (AR) is a widely-used Chinese herbal medicine containing multiple active lignans and rare nephrotoxic components-aristolochic acids derivatives (AAs). However, the current quality control method carried out by Chinese Pharmacopoeia has defects in trace AAs detection and insufficient marker ingredients, which is unable to comprehensively evaluate the efficacy and safety of AR. To improve the quality control method of AR, a rapid, sensitive, and reliable chromatographic analytic method based on ultra-high-performance liquid chromatography-triple quadrupole tandem mass spectrometry (UHPLC-QqQ-MS) was established for the simultaneous analysis of multiple AAs and lignans in AR samples. Positive electrospray ionization mode with multiple reaction monitoring (MRM) was applied for the detection of the eight analytes. The method showed available linearity (R2 ≥ 0.991), the limit of quantification (2–5 ng/mL), precision (RSD <8.12%), and accuracy (89.78–112.16%). A total of 6 AAs and 2 lignans were quantified for their content in 15 AR samples. The content of AA-IVa, AA-VIIa, and aristololactam I (AL-I) was much higher than the AA-I controlled by pharmacopoeia. Considering the potential toxicity of AAs, AA-IVa, AA-VIIa, and AL-I should also be controlled in AR. A considerable amount of active sesamin was detected in AR, suggesting that it could be added as a quality marker for the quality control of AR. The newly developed analytical method could be applied for the fast evaluation of toxic AA’s content and quality during quality control of AR or preparations containing AR.